Salorino, Switzerland

Francesca Viti

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 3.1

ph-index = 10

Forward Citations = 274(Granted Patents)


Location History:

  • Sesto San Giovanni, IT (2013 - 2019)
  • Mendrisio, CH (2023)
  • Salorino, CH (2016 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Francesca Viti

Introduction: Francesca Viti, a prominent inventor based in Salorino, CH, has made significant contributions to the field of biomedical innovations. With a remarkable portfolio of 26 patents, her work focuses on developing therapies for inflammatory diseases and conditions through novel compounds and their applications.

Latest Patents: Among Francesca's latest patents are innovative treatments targeting IL-34 and aryl hydrocarbon receptors. The first patent, titled "IL-34 antisense agents and methods of using same," details polynucleotides complementary to IL-34, encompassing IL-34 antisense oligonucleotides and IL-34 NAs. This invention outlines methods for treating inflammatory diseases, such as inflammatory bowel disease, and fibrosis linked to elevated IL-34 activity. Furthermore, pharmaceutical compositions utilizing these polynucleotides aim to enhance therapeutic outcomes in managing such conditions.

The second patent, "Aryl receptor modulators and methods of making and using the same," revolves around creating compounds that effectively bind to the aryl hydrocarbon receptor. This patent introduces new methods for treating inflammatory conditions, including Crohn's disease, and outlines pharmaceutical compositions that aid in increasing IL-22 levels while decreasing IFN-γ levels in patients.

Career Highlights: Francesca Viti's career has been marked by relentless innovation and dedication to improving therapeutic approaches in the biomedical field. Her position at Nogra Pharma Limited has allowed her to spearhead transformative research and development efforts, ultimately contributing to her substantial patent portfolio.

Collaborations: Throughout her career, Francesca has collaborated with esteemed colleagues such as Salvatore Bellinvia and Sergio Baroni. These partnerships have fostered an environment of creativity and innovation, enhancing the advancements in therapeutics she has contributed to.

Conclusion: Francesca Viti's contributions to patentable innovations in the biomedical sector underscore her commitment to addressing significant health challenges. Through her patents aimed at treating inflammatory diseases, she continues to make a meaningful impact on medical science, showcasing the critical role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…